{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T10:44:33Z","timestamp":1743072273246,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":13,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071637852"},{"type":"electronic","value":"9781071637869"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3786-9_22","type":"book-chapter","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T16:03:05Z","timestamp":1710950585000},"page":"217-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methods for Analysis of Nanoparticle Immunosuppressive Properties"],"prefix":"10.1007","author":[{"given":"Edward","family":"Cedrone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry W.","family":"Neun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina A.","family":"Dobrovolskaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"11","key":"22_CR1","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrd2423","volume":"6","author":"RA Wilke","year":"2007","unstructured":"Wilke RA, Lin DW, Roden DM, Watkins PB, Flockhart D, Zineh I, Giacomini KM, Krauss RM (2007) Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov 6(11):904\u2013916","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"22_CR2","first-page":"38","volume":"9","author":"DA Smith","year":"2006","unstructured":"Smith DA, Schmid EF (2006) Drug withdrawals and the lessons within. Curr Opin Drug Discov Devel 9(1):38\u201346","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"6","key":"22_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.phr.2004.09.001","volume":"119","author":"DK Wysowski","year":"2004","unstructured":"Wysowski DK, Nourjah P (2004) Analyzing prescription drugs as causes of death on death certificates. Public Health Rep 119(6):520","journal-title":"Public Health Rep"},{"issue":"12","key":"22_CR4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1001\/archinte.165.12.1363","volume":"165","author":"DK Wysowski","year":"2005","unstructured":"Wysowski DK, Swartz L (2005) Adverse drug event surveillance and drug withdrawals in the United States, 1969\u20132002: the importance of reporting suspected reactions. Arch Intern Med 165(12):1363\u20131369","journal-title":"Arch Intern Med"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-60327-198-1_3","volume":"697","author":"K Tyner","year":"2011","unstructured":"Tyner K, Sadrieh N (2011) Considerations when submitting nanotherapeutics to FDA\/CDER for regulatory review. Methods Mol Biol 697:17\u201331","journal-title":"Methods Mol Biol"},{"issue":"5","key":"22_CR6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/wnan.1338","volume":"7","author":"KM Tyner","year":"2015","unstructured":"Tyner KM, Zou P, Yang X, Zhang H, Cruz CN, Lee SL (2015) Product quality for nanomaterials: current U.S. experience and perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7(5):640\u2013654","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"22_CR7","volume-title":"Handbook of immunological properties of engineered nanomaterials","author":"S Bancos","year":"2013","unstructured":"Bancos S, Tyner K, Weaver JL (2013) Immunotoxicity testing for drug\u2013nanoparticle conjugates: regulatory considerations. In: Dobrovolskaia MA, McNeil SE (eds) Handbook of immunological properties of engineered nanomaterials. World Scientififc Publishing, Singapore"},{"issue":"7","key":"22_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nnano.2009.175","volume":"4","author":"MA Dobrovolskaia","year":"2009","unstructured":"Dobrovolskaia MA, Germolec DR, Weaver JL (2009) Evaluation of nanoparticle immunotoxicity. Nat Nanotechnol 4(7):411\u2013414","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"22_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/1547691X.2010.523881","volume":"7","author":"M Collinge","year":"2010","unstructured":"Collinge M, Cole SH, Schneider PA, Donovan CB, Kamperschroer C, Kawabata TT (2010) Human lymphocyte activation assay: an in vitro method for predictive immunotoxicity testing. J Immunotoxicol 7(4):357\u2013366","journal-title":"J Immunotoxicol"},{"key":"22_CR10","first-page":"2791","volume":"6","author":"CC Shen","year":"2011","unstructured":"Shen CC, Liang HJ, Wang CC, Liao MH, Jan TR (2011) A role of cellular glutathione in the differential effects of iron oxide nanoparticles on antigen-specific T cell cytokine expression. Int J Nanomedicine 6:2791\u20132798","journal-title":"Int J Nanomedicine"},{"key":"22_CR11","first-page":"2729","volume":"7","author":"CC Shen","year":"2012","unstructured":"Shen CC, Liang HJ, Wang CC, Liao MH, Jan TR (2012) Iron oxide nanoparticles suppressed T helper 1 cell-mediated immunity in a murine model of delayed-type hypersensitivity. Int J Nanomedicine 7:2729\u20132737","journal-title":"Int J Nanomedicine"},{"key":"22_CR12","first-page":"1229","volume":"6","author":"CC Shen","year":"2011","unstructured":"Shen CC, Wang CC, Liao MH, Jan TR (2011) A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB\/c mice. Int J Nanomedicine 6:1229\u20131235","journal-title":"Int J Nanomedicine"},{"key":"22_CR13","doi-asserted-by":"publisher","unstructured":"Dobrovolskaia MA, McNeil SE (2013) Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release 172(2):456\u2013466. PMID: 23742883; PMCID: PMC5831149. https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.025","DOI":"10.1016\/j.jconrel.2013.05.025"}],"container-title":["Methods in Molecular Biology","Characterization of Nanoparticles Intended for Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3786-9_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T16:04:21Z","timestamp":1710950661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3786-9_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071637852","9781071637869"],"references-count":13,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3786-9_22","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"21 March 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}